Uterine fibroids (leiomyomas or myomas) are benign smooth muscle tumours of the uterus.
They affect up to 70% of women by age 50 and, although non-cancerous, can cause significant morbidity depending on their size, number, and location.
✨ Presentation is highly variable, from asymptomatic cases to severe menstrual disturbance and reproductive complications.
🧩 Types of Fibroids
- Intramural: Within the uterine wall – most common, often causes menorrhagia and bulk symptoms.
- Submucosal: Beneath the endometrium → heavy menstrual bleeding + infertility risk.
- Subserosal: Beneath the serosa → may grow large, pressing on bladder/bowel.
- Pedunculated: Attached by a stalk → risk of torsion and acute pain.
- Cervical: Arise from cervix → may cause obstruction or pressure symptoms.
⚠️ Risk Factors
- 👵 Age: Peak 30–50 years.
- 🧬 Family History: Increased risk if first-degree relatives affected.
- 🌍 Ethnicity: More common and earlier onset in African-Caribbean women.
- 💊 Hormonal: Oestrogen + progesterone promote growth → shrink after menopause.
- ⚖️ Obesity: Adipose tissue ↑ oestrogen levels.
- 🚫 Nulliparity: Never pregnant = higher risk.
🩺 Clinical Features
- 💉 Menorrhagia: Heavy/prolonged periods (especially submucosal fibroids).
- 😣 Pelvic Pressure: "Dragging" or fullness sensation.
- 🚽 Urinary Symptoms: Frequency, retention (due to bladder compression).
- 💩 Bowel Symptoms: Constipation from rectal pressure.
- ❤️🔥 Dyspareunia: Painful intercourse, esp. cervical fibroids.
- 👶 Reproductive Issues: Infertility, miscarriage, malpresentation, obstructed labour.
- ⚡ Acute Pain: Due to red degeneration (esp. in pregnancy) or torsion of pedunculated fibroid.
- Exam: Enlarged, irregular "lumpy" uterus on bimanual exam; abdominal mass if large.
🔎 Investigations
- 🖤 Ultrasound (TV/TA): First-line to assess size, site, and number.
- 🧲 MRI: For surgical planning or complex cases.
- 🔦 Hysteroscopy: Direct visualisation + removal of submucosal fibroids.
- 💧 Sonohysterography: Saline-infusion scan highlights cavity distortion.
💊 Medical Management
- 🩹 NSAIDs: Symptom relief, ↓ pain (no effect on fibroid size).
- 💊 Hormonal Therapy:
- COCP → regulates bleeding.
- Mirena (LNG-IUS) → ↓ menorrhagia, preserves fertility.
- GnRH Agonists (e.g., leuprolide) → temporary shrinkage, useful pre-op or peri-menopause.
- 🔄 Selective Progesterone Receptor Modulators (e.g., Ulipristal): Shrinks fibroids + controls bleeding.
🔪 Surgical & Interventional Options
- ✂️ Myomectomy: Removes fibroids, uterus preserved → fertility maintained.
- 🏥 Hysterectomy: Definitive option for severe cases, no fertility preservation.
- 🩸 Uterine Artery Embolization (UAE): Cuts off fibroid blood supply → shrinkage. Not recommended if fertility desired.
- 🔥 Endometrial Ablation: For menorrhagia + small submucosal fibroids; not fertility-preserving.
- 🎯 MR-guided Focused Ultrasound: Non-invasive thermal destruction under MRI guidance.
🚑 Complications
- 💉 Iron-Deficiency Anaemia: From chronic menorrhagia.
- 👶 Infertility & Miscarriage: Submucosal fibroids distort uterine cavity.
- 🤰 Pregnancy Complications: Malpresentation, obstructed labour, preterm labour.
- ⚡ Red Degeneration: Painful necrosis, esp. in pregnancy.
- 🚽 Urinary Retention / Recurrent UTIs: From bladder compression.
✅ Key Exam Pearls
- Fibroids are **oestrogen-dependent** → shrink after menopause.
- Most common type: **intramural**.
- Most symptomatic for bleeding: **submucosal**.
- Definitive treatment: **hysterectomy**.